开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2157407, encodeId=928d215e40747, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：已中，要求合理，就是有点久。影响因子不高因为是非OA为主，少有的低分需要图片摘要进行说明的期刊。看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0775546096, createdName=ms3000001161611445, createdTime=Tue Sep 12 21:47:50 CST 2023, time=2023-09-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1229140, encodeId=522c1229140d6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白质 经验分享：编辑很专业效率也很高，每封邮件回复都很及时，另外润色费也是很便宜的，就是终审有点慢，还没收到完全接收的邮件，再等等，有消息就更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12b65702750, createdName=ms5000000359930993, createdTime=Tue Jun 28 13:21:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091567, encodeId=6684209156e8a, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投了一篇综述，2.10投稿，5.9一审结束，审稿人只提了几个小问题，送了润色，一周后修回，5.22收到临时接收的邮件。8.5和8.18两次proof，然后就online了，现在还没有见刊。总体来说偏慢，但是比较容易中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 03 10:18:34 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222328, encodeId=b7fd1222328b2, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药学 经验分享：4月12号投稿，5月24号送审，中间修改过一次格式，现在结果未知，希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d11e2208303, createdName=120cd24bm30(暂无昵称), createdTime=Wed May 25 15:03:23 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226444, encodeId=76ff122644420, content=6月5号修回后，一直没消息，不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90d42326387, createdName=1225ebb0m52(暂无昵称), createdTime=Tue Jun 14 18:15:11 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099335, encodeId=3120109933569, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099336, encodeId=a7ea1099336bd, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540175, encodeId=01745401e5a9, content=虽然今年没有什么大变化，以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533685, encodeId=239c53368572, content=求助，这个期刊审稿时间一般是多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=420, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3122030018, createdName=PeiPei.., createdTime=Fri Mar 03 12:23:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832310, encodeId=089f832310d7, content=审稿速度:3.0 经验分享：这个杂志还是很不错的，杂志工作效率高，学术editor很认真、很负责，reviewer提了很多建设性修改意见，都很专业。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a25413959, createdName=ms4895215858607754, createdTime=Wed Jun 01 22:27:42 CST 2016, time=2016-06-01, status=1, ipAttribution=)]

2023-09-12 ms3000001161611445 来自广东省

审稿速度:24.0 | 投稿命中率:50.0
经验分享：已中，要求合理，就是有点久。影响因子不高因为是非OA为主，少有的低分需要图片摘要进行说明的期刊。看好。

71 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157407, encodeId=928d215e40747, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：已中，要求合理，就是有点久。影响因子不高因为是非OA为主，少有的低分需要图片摘要进行说明的期刊。看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0775546096, createdName=ms3000001161611445, createdTime=Tue Sep 12 21:47:50 CST 2023, time=2023-09-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1229140, encodeId=522c1229140d6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白质 经验分享：编辑很专业效率也很高，每封邮件回复都很及时，另外润色费也是很便宜的，就是终审有点慢，还没收到完全接收的邮件，再等等，有消息就更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12b65702750, createdName=ms5000000359930993, createdTime=Tue Jun 28 13:21:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091567, encodeId=6684209156e8a, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投了一篇综述，2.10投稿，5.9一审结束，审稿人只提了几个小问题，送了润色，一周后修回，5.22收到临时接收的邮件。8.5和8.18两次proof，然后就online了，现在还没有见刊。总体来说偏慢，但是比较容易中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 03 10:18:34 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222328, encodeId=b7fd1222328b2, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药学 经验分享：4月12号投稿，5月24号送审，中间修改过一次格式，现在结果未知，希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d11e2208303, createdName=120cd24bm30(暂无昵称), createdTime=Wed May 25 15:03:23 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226444, encodeId=76ff122644420, content=6月5号修回后，一直没消息，不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90d42326387, createdName=1225ebb0m52(暂无昵称), createdTime=Tue Jun 14 18:15:11 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099335, encodeId=3120109933569, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099336, encodeId=a7ea1099336bd, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540175, encodeId=01745401e5a9, content=虽然今年没有什么大变化，以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533685, encodeId=239c53368572, content=求助，这个期刊审稿时间一般是多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=420, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3122030018, createdName=PeiPei.., createdTime=Fri Mar 03 12:23:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832310, encodeId=089f832310d7, content=审稿速度:3.0 经验分享：这个杂志还是很不错的，杂志工作效率高，学术editor很认真、很负责，reviewer提了很多建设性修改意见，都很专业。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a25413959, createdName=ms4895215858607754, createdTime=Wed Jun 01 22:27:42 CST 2016, time=2016-06-01, status=1, ipAttribution=)]

2022-06-28 ms5000000359930993

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：蛋白质
经验分享：编辑很专业效率也很高，每封邮件回复都很及时，另外润色费也是很便宜的，就是终审有点慢，还没收到完全接收的邮件，再等等，有消息就更新

106 15

展开15条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157407, encodeId=928d215e40747, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：已中，要求合理，就是有点久。影响因子不高因为是非OA为主，少有的低分需要图片摘要进行说明的期刊。看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0775546096, createdName=ms3000001161611445, createdTime=Tue Sep 12 21:47:50 CST 2023, time=2023-09-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1229140, encodeId=522c1229140d6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白质 经验分享：编辑很专业效率也很高，每封邮件回复都很及时，另外润色费也是很便宜的，就是终审有点慢，还没收到完全接收的邮件，再等等，有消息就更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12b65702750, createdName=ms5000000359930993, createdTime=Tue Jun 28 13:21:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091567, encodeId=6684209156e8a, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投了一篇综述，2.10投稿，5.9一审结束，审稿人只提了几个小问题，送了润色，一周后修回，5.22收到临时接收的邮件。8.5和8.18两次proof，然后就online了，现在还没有见刊。总体来说偏慢，但是比较容易中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 03 10:18:34 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222328, encodeId=b7fd1222328b2, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药学 经验分享：4月12号投稿，5月24号送审，中间修改过一次格式，现在结果未知，希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d11e2208303, createdName=120cd24bm30(暂无昵称), createdTime=Wed May 25 15:03:23 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226444, encodeId=76ff122644420, content=6月5号修回后，一直没消息，不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90d42326387, createdName=1225ebb0m52(暂无昵称), createdTime=Tue Jun 14 18:15:11 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099335, encodeId=3120109933569, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099336, encodeId=a7ea1099336bd, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540175, encodeId=01745401e5a9, content=虽然今年没有什么大变化，以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533685, encodeId=239c53368572, content=求助，这个期刊审稿时间一般是多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=420, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3122030018, createdName=PeiPei.., createdTime=Fri Mar 03 12:23:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832310, encodeId=089f832310d7, content=审稿速度:3.0 经验分享：这个杂志还是很不错的，杂志工作效率高，学术editor很认真、很负责，reviewer提了很多建设性修改意见，都很专业。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a25413959, createdName=ms4895215858607754, createdTime=Wed Jun 01 22:27:42 CST 2016, time=2016-06-01, status=1, ipAttribution=)]

2022-10-03 ms5000001856769052

审稿速度:3.0 | 投稿命中率:75.0
经验分享：投了一篇综述，2.10投稿，5.9一审结束，审稿人只提了几个小问题，送了润色，一周后修回，5.22收到临时接收的邮件。8.5和8.18两次proof，然后就online了，现在还没有见刊。总体来说偏慢，但是比较容易中。

78 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157407, encodeId=928d215e40747, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：已中，要求合理，就是有点久。影响因子不高因为是非OA为主，少有的低分需要图片摘要进行说明的期刊。看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0775546096, createdName=ms3000001161611445, createdTime=Tue Sep 12 21:47:50 CST 2023, time=2023-09-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1229140, encodeId=522c1229140d6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白质 经验分享：编辑很专业效率也很高，每封邮件回复都很及时，另外润色费也是很便宜的，就是终审有点慢，还没收到完全接收的邮件，再等等，有消息就更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12b65702750, createdName=ms5000000359930993, createdTime=Tue Jun 28 13:21:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091567, encodeId=6684209156e8a, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投了一篇综述，2.10投稿，5.9一审结束，审稿人只提了几个小问题，送了润色，一周后修回，5.22收到临时接收的邮件。8.5和8.18两次proof，然后就online了，现在还没有见刊。总体来说偏慢，但是比较容易中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 03 10:18:34 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222328, encodeId=b7fd1222328b2, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药学 经验分享：4月12号投稿，5月24号送审，中间修改过一次格式，现在结果未知，希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d11e2208303, createdName=120cd24bm30(暂无昵称), createdTime=Wed May 25 15:03:23 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226444, encodeId=76ff122644420, content=6月5号修回后，一直没消息，不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90d42326387, createdName=1225ebb0m52(暂无昵称), createdTime=Tue Jun 14 18:15:11 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099335, encodeId=3120109933569, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099336, encodeId=a7ea1099336bd, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540175, encodeId=01745401e5a9, content=虽然今年没有什么大变化，以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533685, encodeId=239c53368572, content=求助，这个期刊审稿时间一般是多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=420, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3122030018, createdName=PeiPei.., createdTime=Fri Mar 03 12:23:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832310, encodeId=089f832310d7, content=审稿速度:3.0 经验分享：这个杂志还是很不错的，杂志工作效率高，学术editor很认真、很负责，reviewer提了很多建设性修改意见，都很专业。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a25413959, createdName=ms4895215858607754, createdTime=Wed Jun 01 22:27:42 CST 2016, time=2016-06-01, status=1, ipAttribution=)]

2022-05-25 120cd24bm30(暂无昵称)

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：药学
经验分享：4月12号投稿，5月24号送审，中间修改过一次格式，现在结果未知，希望能中

79 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157407, encodeId=928d215e40747, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：已中，要求合理，就是有点久。影响因子不高因为是非OA为主，少有的低分需要图片摘要进行说明的期刊。看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0775546096, createdName=ms3000001161611445, createdTime=Tue Sep 12 21:47:50 CST 2023, time=2023-09-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1229140, encodeId=522c1229140d6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白质 经验分享：编辑很专业效率也很高，每封邮件回复都很及时，另外润色费也是很便宜的，就是终审有点慢，还没收到完全接收的邮件，再等等，有消息就更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12b65702750, createdName=ms5000000359930993, createdTime=Tue Jun 28 13:21:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091567, encodeId=6684209156e8a, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投了一篇综述，2.10投稿，5.9一审结束，审稿人只提了几个小问题，送了润色，一周后修回，5.22收到临时接收的邮件。8.5和8.18两次proof，然后就online了，现在还没有见刊。总体来说偏慢，但是比较容易中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 03 10:18:34 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222328, encodeId=b7fd1222328b2, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药学 经验分享：4月12号投稿，5月24号送审，中间修改过一次格式，现在结果未知，希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d11e2208303, createdName=120cd24bm30(暂无昵称), createdTime=Wed May 25 15:03:23 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226444, encodeId=76ff122644420, content=6月5号修回后，一直没消息，不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90d42326387, createdName=1225ebb0m52(暂无昵称), createdTime=Tue Jun 14 18:15:11 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099335, encodeId=3120109933569, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099336, encodeId=a7ea1099336bd, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540175, encodeId=01745401e5a9, content=虽然今年没有什么大变化，以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533685, encodeId=239c53368572, content=求助，这个期刊审稿时间一般是多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=420, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3122030018, createdName=PeiPei.., createdTime=Fri Mar 03 12:23:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832310, encodeId=089f832310d7, content=审稿速度:3.0 经验分享：这个杂志还是很不错的，杂志工作效率高，学术editor很认真、很负责，reviewer提了很多建设性修改意见，都很专业。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a25413959, createdName=ms4895215858607754, createdTime=Wed Jun 01 22:27:42 CST 2016, time=2016-06-01, status=1, ipAttribution=)]

2022-06-14 1225ebb0m52(暂无昵称)

6月5号修回后，一直没消息，不知道还要等多久

94 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157407, encodeId=928d215e40747, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：已中，要求合理，就是有点久。影响因子不高因为是非OA为主，少有的低分需要图片摘要进行说明的期刊。看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0775546096, createdName=ms3000001161611445, createdTime=Tue Sep 12 21:47:50 CST 2023, time=2023-09-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1229140, encodeId=522c1229140d6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白质 经验分享：编辑很专业效率也很高，每封邮件回复都很及时，另外润色费也是很便宜的，就是终审有点慢，还没收到完全接收的邮件，再等等，有消息就更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12b65702750, createdName=ms5000000359930993, createdTime=Tue Jun 28 13:21:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091567, encodeId=6684209156e8a, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投了一篇综述，2.10投稿，5.9一审结束，审稿人只提了几个小问题，送了润色，一周后修回，5.22收到临时接收的邮件。8.5和8.18两次proof，然后就online了，现在还没有见刊。总体来说偏慢，但是比较容易中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 03 10:18:34 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222328, encodeId=b7fd1222328b2, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药学 经验分享：4月12号投稿，5月24号送审，中间修改过一次格式，现在结果未知，希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d11e2208303, createdName=120cd24bm30(暂无昵称), createdTime=Wed May 25 15:03:23 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226444, encodeId=76ff122644420, content=6月5号修回后，一直没消息，不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90d42326387, createdName=1225ebb0m52(暂无昵称), createdTime=Tue Jun 14 18:15:11 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099335, encodeId=3120109933569, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099336, encodeId=a7ea1099336bd, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540175, encodeId=01745401e5a9, content=虽然今年没有什么大变化，以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533685, encodeId=239c53368572, content=求助，这个期刊审稿时间一般是多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=420, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3122030018, createdName=PeiPei.., createdTime=Fri Mar 03 12:23:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832310, encodeId=089f832310d7, content=审稿速度:3.0 经验分享：这个杂志还是很不错的，杂志工作效率高，学术editor很认真、很负责，reviewer提了很多建设性修改意见，都很专业。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a25413959, createdName=ms4895215858607754, createdTime=Wed Jun 01 22:27:42 CST 2016, time=2016-06-01, status=1, ipAttribution=)]

2021-12-27 小动量

回复评审的意见和期刊编辑的意见有什么不同？

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157407, encodeId=928d215e40747, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：已中，要求合理，就是有点久。影响因子不高因为是非OA为主，少有的低分需要图片摘要进行说明的期刊。看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0775546096, createdName=ms3000001161611445, createdTime=Tue Sep 12 21:47:50 CST 2023, time=2023-09-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1229140, encodeId=522c1229140d6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白质 经验分享：编辑很专业效率也很高，每封邮件回复都很及时，另外润色费也是很便宜的，就是终审有点慢，还没收到完全接收的邮件，再等等，有消息就更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12b65702750, createdName=ms5000000359930993, createdTime=Tue Jun 28 13:21:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091567, encodeId=6684209156e8a, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投了一篇综述，2.10投稿，5.9一审结束，审稿人只提了几个小问题，送了润色，一周后修回，5.22收到临时接收的邮件。8.5和8.18两次proof，然后就online了，现在还没有见刊。总体来说偏慢，但是比较容易中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 03 10:18:34 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222328, encodeId=b7fd1222328b2, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药学 经验分享：4月12号投稿，5月24号送审，中间修改过一次格式，现在结果未知，希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d11e2208303, createdName=120cd24bm30(暂无昵称), createdTime=Wed May 25 15:03:23 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226444, encodeId=76ff122644420, content=6月5号修回后，一直没消息，不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90d42326387, createdName=1225ebb0m52(暂无昵称), createdTime=Tue Jun 14 18:15:11 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099335, encodeId=3120109933569, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099336, encodeId=a7ea1099336bd, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540175, encodeId=01745401e5a9, content=虽然今年没有什么大变化，以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533685, encodeId=239c53368572, content=求助，这个期刊审稿时间一般是多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=420, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3122030018, createdName=PeiPei.., createdTime=Fri Mar 03 12:23:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832310, encodeId=089f832310d7, content=审稿速度:3.0 经验分享：这个杂志还是很不错的，杂志工作效率高，学术editor很认真、很负责，reviewer提了很多建设性修改意见，都很专业。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a25413959, createdName=ms4895215858607754, createdTime=Wed Jun 01 22:27:42 CST 2016, time=2016-06-01, status=1, ipAttribution=)]

2021-12-27 Gym璨烨

评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？

95 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157407, encodeId=928d215e40747, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：已中，要求合理，就是有点久。影响因子不高因为是非OA为主，少有的低分需要图片摘要进行说明的期刊。看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0775546096, createdName=ms3000001161611445, createdTime=Tue Sep 12 21:47:50 CST 2023, time=2023-09-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1229140, encodeId=522c1229140d6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白质 经验分享：编辑很专业效率也很高，每封邮件回复都很及时，另外润色费也是很便宜的，就是终审有点慢，还没收到完全接收的邮件，再等等，有消息就更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12b65702750, createdName=ms5000000359930993, createdTime=Tue Jun 28 13:21:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091567, encodeId=6684209156e8a, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投了一篇综述，2.10投稿，5.9一审结束，审稿人只提了几个小问题，送了润色，一周后修回，5.22收到临时接收的邮件。8.5和8.18两次proof，然后就online了，现在还没有见刊。总体来说偏慢，但是比较容易中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 03 10:18:34 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222328, encodeId=b7fd1222328b2, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药学 经验分享：4月12号投稿，5月24号送审，中间修改过一次格式，现在结果未知，希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d11e2208303, createdName=120cd24bm30(暂无昵称), createdTime=Wed May 25 15:03:23 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226444, encodeId=76ff122644420, content=6月5号修回后，一直没消息，不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90d42326387, createdName=1225ebb0m52(暂无昵称), createdTime=Tue Jun 14 18:15:11 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099335, encodeId=3120109933569, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099336, encodeId=a7ea1099336bd, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540175, encodeId=01745401e5a9, content=虽然今年没有什么大变化，以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533685, encodeId=239c53368572, content=求助，这个期刊审稿时间一般是多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=420, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3122030018, createdName=PeiPei.., createdTime=Fri Mar 03 12:23:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832310, encodeId=089f832310d7, content=审稿速度:3.0 经验分享：这个杂志还是很不错的，杂志工作效率高，学术editor很认真、很负责，reviewer提了很多建设性修改意见，都很专业。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a25413959, createdName=ms4895215858607754, createdTime=Wed Jun 01 22:27:42 CST 2016, time=2016-06-01, status=1, ipAttribution=)]

2017-07-18 yang_liping1

虽然今年没有什么大变化，以后再看看

369 0

[GetPortalCommentsPageByObjectIdResponse(id=2157407, encodeId=928d215e40747, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：已中，要求合理，就是有点久。影响因子不高因为是非OA为主，少有的低分需要图片摘要进行说明的期刊。看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0775546096, createdName=ms3000001161611445, createdTime=Tue Sep 12 21:47:50 CST 2023, time=2023-09-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1229140, encodeId=522c1229140d6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白质 经验分享：编辑很专业效率也很高，每封邮件回复都很及时，另外润色费也是很便宜的，就是终审有点慢，还没收到完全接收的邮件，再等等，有消息就更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12b65702750, createdName=ms5000000359930993, createdTime=Tue Jun 28 13:21:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091567, encodeId=6684209156e8a, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投了一篇综述，2.10投稿，5.9一审结束，审稿人只提了几个小问题，送了润色，一周后修回，5.22收到临时接收的邮件。8.5和8.18两次proof，然后就online了，现在还没有见刊。总体来说偏慢，但是比较容易中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 03 10:18:34 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222328, encodeId=b7fd1222328b2, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药学 经验分享：4月12号投稿，5月24号送审，中间修改过一次格式，现在结果未知，希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d11e2208303, createdName=120cd24bm30(暂无昵称), createdTime=Wed May 25 15:03:23 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226444, encodeId=76ff122644420, content=6月5号修回后，一直没消息，不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90d42326387, createdName=1225ebb0m52(暂无昵称), createdTime=Tue Jun 14 18:15:11 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099335, encodeId=3120109933569, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099336, encodeId=a7ea1099336bd, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540175, encodeId=01745401e5a9, content=虽然今年没有什么大变化，以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533685, encodeId=239c53368572, content=求助，这个期刊审稿时间一般是多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=420, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3122030018, createdName=PeiPei.., createdTime=Fri Mar 03 12:23:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832310, encodeId=089f832310d7, content=审稿速度:3.0 经验分享：这个杂志还是很不错的，杂志工作效率高，学术editor很认真、很负责，reviewer提了很多建设性修改意见，都很专业。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a25413959, createdName=ms4895215858607754, createdTime=Wed Jun 01 22:27:42 CST 2016, time=2016-06-01, status=1, ipAttribution=)]

2017-03-03 PeiPei..

求助，这个期刊审稿时间一般是多久

420 0

[GetPortalCommentsPageByObjectIdResponse(id=2157407, encodeId=928d215e40747, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：已中，要求合理，就是有点久。影响因子不高因为是非OA为主，少有的低分需要图片摘要进行说明的期刊。看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0775546096, createdName=ms3000001161611445, createdTime=Tue Sep 12 21:47:50 CST 2023, time=2023-09-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1229140, encodeId=522c1229140d6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白质 经验分享：编辑很专业效率也很高，每封邮件回复都很及时，另外润色费也是很便宜的，就是终审有点慢，还没收到完全接收的邮件，再等等，有消息就更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12b65702750, createdName=ms5000000359930993, createdTime=Tue Jun 28 13:21:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091567, encodeId=6684209156e8a, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投了一篇综述，2.10投稿，5.9一审结束，审稿人只提了几个小问题，送了润色，一周后修回，5.22收到临时接收的邮件。8.5和8.18两次proof，然后就online了，现在还没有见刊。总体来说偏慢，但是比较容易中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 03 10:18:34 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222328, encodeId=b7fd1222328b2, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药学 经验分享：4月12号投稿，5月24号送审，中间修改过一次格式，现在结果未知，希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d11e2208303, createdName=120cd24bm30(暂无昵称), createdTime=Wed May 25 15:03:23 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226444, encodeId=76ff122644420, content=6月5号修回后，一直没消息，不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90d42326387, createdName=1225ebb0m52(暂无昵称), createdTime=Tue Jun 14 18:15:11 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099335, encodeId=3120109933569, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099336, encodeId=a7ea1099336bd, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540175, encodeId=01745401e5a9, content=虽然今年没有什么大变化，以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533685, encodeId=239c53368572, content=求助，这个期刊审稿时间一般是多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=420, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3122030018, createdName=PeiPei.., createdTime=Fri Mar 03 12:23:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832310, encodeId=089f832310d7, content=审稿速度:3.0 经验分享：这个杂志还是很不错的，杂志工作效率高，学术editor很认真、很负责，reviewer提了很多建设性修改意见，都很专业。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a25413959, createdName=ms4895215858607754, createdTime=Wed Jun 01 22:27:42 CST 2016, time=2016-06-01, status=1, ipAttribution=)]

2016-06-01 ms4895215858607754

审稿速度:3.0
经验分享：这个杂志还是很不错的，杂志工作效率高，学术editor很认真、很负责，reviewer提了很多建设性修改意见，都很专业。

167 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务